Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Evy, Vandemeulebroucke"'
Autor:
Johannes Ruige, Ilse Weets, Pieter Gillard, Frans Gorus, Belgian Diabetes Registry, An Walgraeve, Eric V. Balti, Simke Demeester, Daniel Pipeleers, Annelien Van Dalem, Bart Keymeulen, Evy Vandemeulebroucke, Ursule Van de Velde, Christophe De Block, Nicole Seret, Katelijn Decochez
Publikováno v:
Diabetologia
We examined whether measures of glycaemic variability (GV), assessed by continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG), can complement or replace measures of beta cell function and insulin action in detecting the prog
Autor:
Eric V, Balti, Evy, Vandemeulebroucke, Ilse, Weets, Ursule, Van De Velde, Annelien, Van Dalem, Simke, Demeester, Katrijn, Verhaeghen, Pieter, Gillard, Christophe, De Block, Johannes, Ruige, Bart, Keymeulen, Daniel G, Pipeleers, Katelijn, Decochez, Frans K, Gorus, R, Van Heyste
Publikováno v:
The journal of clinical endocrinology and metabolism
Context and Objective: In preparation of future prevention trials, we aimed to identify predictors of 3-year diabetes onset among oral glucose tolerance test (OGTT)- and hyperglycemic clamp-derived metabolic markers in persistently islet autoantibody
Autor:
L Kaufman, Chantal Mathieu, Evy Vandemeulebroucke, Daniel Pipeleers, Herman Waldmann, Anette-G. Ziegler, Sophie Candon, U Van de Velde, Lucienne Chatenoud, Robert Hilbrands, Laurent Crenier, C De Block, Bart Keymeulen, M Walter, F. K. Gorus
Publikováno v:
Vrije Universiteit Brussel
Diabetologia
Diabetologia
AIMS/HYPOTHESIS: The aim of the study was to examine the 48 month outcome of treating recent-onset type 1 diabetic patients for 6 days with humanised CD3-antibody, ChAglyCD3. METHODS: Eighty patients, aged 12-39 years, were recruited for a phase 2 mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25660f81be5b020ec93b22bf5ee7fc08
https://doi.org/10.1007/s00125-009-1644-9
https://doi.org/10.1007/s00125-009-1644-9
Autor:
Bart Keymeulen, Gonnie M. Alkemade, Herman Waldmann, Evy Vandemeulebroucke, Chantal Mathieu, Daniel Pipeleers, Robert Hilbrands, Bart O. Roep
Publikováno v:
Vrije Universiteit Brussel
Diabetes/Metabolism Research and Reviews, 27(8), 925-7
Diabetes/Metabolism Research and Reviews
Diabetes/Metabolism Research and Reviews, 27(8), 925-7
Diabetes/Metabolism Research and Reviews
Background The safety of any immune modulating agent in type 1 diabetes mellitus (T1DM) involves its selectivity on autoimmunity and its preservation of recall and tumour immunity. Methods We performed lymphocyte proliferation tests on seven recent o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdeddeda1eb4bfbe4ae879f0e2ffd7f0
http://hdl.handle.net/1887/111273
http://hdl.handle.net/1887/111273
Autor:
Evy Vandemeulebroucke, Peppy Rebello, Ibrahim Al Bakir, William J. Jusko, E Bolam, Paweł Wiczling, Annette-G Ziegler, Chantal Mathieu, Bart Keymeulen, Geoff Hale, Lucienne Chatenoud, Herman Waldmann
Publikováno v:
Journal of clinical pharmacology. 50(11)
Otelixizumab is a chimeric CD3 antibody that has been genetically engineered to remove the glycosylation site in the Fc domain. This limits its ability to bind to complement or Fc receptors and reduces the risk of adverse clinical reactions due to cy
Autor:
M Walter, Jean Marie Seigneurin, Geoff Hale, Lucienne Chatenoud, Samira Fafi-Kremer, Evy Vandemeulebroucke, Denis Pierard, Bart Keymeulen, Herman Waldmann, Eric Thervet, Christophe Legendre, Daniel Pipeleers, Jean-François Bach, Chantal Mathieu, Laurent Crenier, Anette-G. Ziegler, Marianne Leruez-Ville, Sophie Candon
Publikováno v:
Vrije Universiteit Brussel
Here we report a unique situation in which an early and synchronized Epstein-Barr virus (EBV) reactivation was induced by a 6-day course of treatment with a humanized CD3-specific monoclonal antibody in patients with recent onset of type 1 diabetes.
Autor:
Chantal Mathieu, Pieter Gillard, Daniel Pipeleers, Pieter De Pauw, Bart Keymeulen, Jacques Pirenne, Evy Vandemeulebroucke, Yves Vanrenterghem, Bart Maes
Publikováno v:
Transplantation. 87(3)
BACKGROUND: To compare functional beta-cell mass and insulin sensitivity in insulin-independent pancreas-kidney recipients with that in age- and body mass index-matched nondiabetic kidney recipients and normal controls. METHODS: All transplant recipi
Autor:
Evy Vandemeulebroucke, Frans Gorus, Katelijn Decochez, Ilse Weets, Bart Keymeulen, Block, C., Tits, J., Daniel Pipeleers, Mathieu, C.
Publikováno v:
Vrije Universiteit Brussel
AIMS: We examined whether parenteral regular insulin can prevent diabetes in IA-2 antibody-positive (IA-2A+) relatives of type 1 diabetic patients, using a trial protocol that differed substantially from that of the Diabetes Prevention Trial-1. METHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::18c28813794fffc8e389f5300af3bf25
https://biblio.vub.ac.be/vubir/insulin-treatment-in-ia2-antibody-positive-relatives-of-type-1-diabetic-patients(84a986de-daa2-4485-9020-77dcce42d45e).html
https://biblio.vub.ac.be/vubir/insulin-treatment-in-ia2-antibody-positive-relatives-of-type-1-diabetic-patients(84a986de-daa2-4485-9020-77dcce42d45e).html
Autor:
Evy Vandemeulebroucke, Danielle Gnat, Françoise Vertongen, M Dramaix, Wael Shabana, François Delange, A Van Onderbergen
OBJECTIVE: Belgium is one of the Western European countries in which no program of iodine-deficiency correction using iodized salt has been implemented, in spite of well-documented mild iodine deficiency. In 1995, the median urinary iodine concentrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77bd54e0e4a94b940567b724b95ac55c
https://biblio.vub.ac.be/vubir/silent-iodine-prophylaxis-in-western-europe-only-partly-corrects-iodine-deficiency-the-case-of-belgium(1e6dd5ed-3422-48e0-84e4-0d5c90450a50).html
https://biblio.vub.ac.be/vubir/silent-iodine-prophylaxis-in-western-europe-only-partly-corrects-iodine-deficiency-the-case-of-belgium(1e6dd5ed-3422-48e0-84e4-0d5c90450a50).html
Autor:
Kris Doggen, Chantal Mathieu, Ann Verhaegen, Evy Vandemeulebroucke, Astrid Lavens, Viviane Van Casteren, Michel Vandenbroucke, Frank Nobels
Publikováno v:
BMC Health Services Research
Background Assessment of quality of care using classical threshold measures (TM) is open to debate. Measures that take into account the clinician’s actions and the longitudinal nature of chronic care are more reliable, although their major limitati